Temple Massager System Study in Women Ages 35-65

Starting soon

Conditions studied: Tension Headaches, Stress, Sleep Quality, Quality of Life

In brief

The goal of this observational study is to learn how the Temple Massager System affects stress, emotional wellbeing, sleep, and quality of life in women aged 35 to 65. The Temple Massager System is a non-electric, drug-free hand-held device used for self-massage of the temple area. The system also includes a body lotion and an optional lavender aromatherapy. It is sold as a general wellness product. The main questions this study aims to answer are: Does daily use of the Temple Massager System lower self-reported stress and improve emotional wellbeing over 4 weeks? Does daily use improve self-reported sleep quality and overall quality of life? This is a single-arm observational study. There is no placebo or comparison group. Researchers will compare how participants feel before they start using the device to how they feel after 4 weeks of daily use. Participants will: Receive a Temple Massager System at no cost Complete a 1-week baseline period before using the device Use the device once a day for at least 5 minutes for 4 weeks Answer short daily questions about device use, headaches, and over-the-counter medication use Complete weekly check-in surveys about stress, mood, and sleep Complete longer surveys at the start and end of the study Keep the device after the study ends The study runs for 5 weeks per participant and takes place entirely from home through a secure app-based platform. No clinic visits are required.

Key facts

Study ID: NCT07639658
Run by: MOQ Collective, Ltd
People needed: 48
Starts: 2026-06-10
Expected to finish: 2026-09-30
Last updated by the study team: 2026-06-10

Who can join

Age: 35 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

Female, aged 35-65 years old, inclusive
Self-reported experience of daily stress, anxiety, tension headaches, facial tension, or TMJ-related discomfort
Headache frequency of 2 or more per week (self-reported)
If taking any prescription medication including SSRIs, anxiolytics, sleep medications, hormonal therapies, or blood pressure medications, must be on a stable dose for at least 4 weeks prior to study enrollment and throughout the course of the study
In good general health at the time of screening (Investigator discretion)
Able to read and understand English
Able to read, understand, and provide informed consent
Able to use a personal smartphone or tablet and access the study platform for daily data entry
Able to receive shipment of the study product at an address within the United States
Willing and able to use the Temple Massager System daily for 4 weeks

You may not qualify if…

No personal smartphone or tablet, no internet access, or unwilling to use the study platform
Known allergy or sensitivity to lavender oil, mango butter, shea butter, arnica, or St. John's Wort (Note: lavender sensitivity alone is not exclusionary; an aromatherapy sensitivity protocol applies)
Active skin infection or open wounds on the face or temple area
Diagnosed trigeminal neuralgia or other cranial nerve pathology
Diagnosed vascular issues affecting the head or face: temporal arteritis, aneurysm, or cerebrovascular malformations
Bleeding disorders: history of easy bruising or bleeding in the face/head area, or current use of prescribed blood thinners (anticoagulants) such as Warfarin or Eliquis
Any surgery on the jaw, temples, or face within the last 6 months
Active inflammation: current redness, swelling, or extreme tenderness specifically over the temple arteries
Current use of prescription headache medications (triptans, topiramate, muscle relaxants, beta-blockers for migraine prophylaxis, or other prescription medications taken primarily for headache management)
Participants currently taking any prescribed medication for sleep or anxiety must be on a stable dose (no dose changes within the past 30 days) to be eligible; participants not on a stable dose are excluded
Current participation in another interventional study
Diagnosed Generalized Anxiety Disorder (GAD)
Currently pregnant, planning to become pregnant during the study period, or breastfeeding
Planned surgical procedure during the study period
Significant illness, disease, or condition which, in the opinion of the Principal Investigator, may impact the ability to participate in the study or impact the study outcomes
Unlikely for any reason to be able to comply with the study or considered unsuited for participation by the Principal Investigator

Where it is running

MOQ Collective, Ltd. — Fairfax, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.